Home » Stocks » ABT

Abbott Laboratories (ABT)

Stock Price: $111.30 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $110.59 -0.71 (-0.64%) Jan 15, 7:55 PM
Market Cap 197.26B
Revenue (ttm) 32.22B
Net Income (ttm) 3.38B
Shares Out 1.77B
EPS (ttm) 1.89
PE Ratio 58.86
Forward PE 25.19
Dividend $1.80
Dividend Yield 1.62%
Trading Day January 15
Last Price $111.30
Previous Close $111.30
Change ($) 0.00
Change (%) 0.00%
Day's Open 110.00
Day's Range 109.39 - 111.62
Day's Volume 4,480,173
52-Week Range 61.86 - 113.96

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Seeking Alpha - 4 days ago

Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 20...

Other stocks mentioned: BDX, CWS, EGBN, GL, HEI, HRL, MLR, RPM, TMO, ZTS
The Motley Fool - 4 days ago

If you sell too quickly, you'll miss out on billions of dollars in product revenue -- and share performance.

Other stocks mentioned: VRTX
The Motley Fool - 4 days ago

Dividends and increasing revenue mean you can count on these companies for safety and growth.

Other stocks mentioned: AZN, TGT
Zacks Investment Research - 5 days ago

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

Other stocks mentioned: BDX, DGX, HOLX, LH, QDEL, QGEN
The Motley Fool - 5 days ago

These stocks are as solid as they come.

Other stocks mentioned: ABBV, JNJ
Seeking Alpha - 6 days ago

Abbott Laboratories (ABT) CEO Robert Ford Presents at 39th Annual J.P. Morgan Healthcare Conference (Transcript)

Other stocks mentioned: F
Zacks Investment Research - 6 days ago

If positive, Abbott's (ABT) TBI blood test result complements CT scans to help evaluate whether a suspected patient has a TBI.

CNBC - 6 days ago

Abbott Labs is making its rapid Covid-19 antigen test available to schools, pharmacies and workplaces that require frequent and affordable testing.

Seeking Alpha - 6 days ago

This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfol...

Other stocks mentioned: BDX, CWS, EGBN, GL, HEI, HRL, MLR, RPM, TMO, ZTS
Zacks Investment Research - 1 week ago

Abbott (ABT) closed the most recent trading day at $111.30, moving +0.97% from the previous trading session.

Seeking Alpha - 1 week ago

All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average increase of 8.4% and a median increase of 6.6%.

Other stocks mentioned: ABBV, CHCO, GGG, MAA, NWFL, RGCO, TRN
The Motley Fool - 1 week ago

The U.S. is focusing on coronavirus testing and vaccination. And that's exactly where these companies excel.

Other stocks mentioned: MRNA
The Motley Fool - 1 week ago

These companies are developing highly competitive vaccines and diagnostics.

Other stocks mentioned: CODX, JNJ
Zacks Investment Research - 1 week ago

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Motley Fool - 2 weeks ago

Companies continue to develop new tests to detect COVID-19.

Other stocks mentioned: QDEL
Forbes - 2 weeks ago

Everyone loves the dividend, but investors usually don't give enough love to the dividend hike.

Other stocks mentioned: AVGO, MA
Zacks Investment Research - 2 weeks ago

Abbott (ABT) closed at $109.49 in the latest trading session, marking a +0.97% move from the prior day.

The Motley Fool - 2 weeks ago

These companies are heavyweights, and they're only getting stronger.

Other stocks mentioned: COST, PFE
The Motley Fool - 3 weeks ago

These companies are in different industries, pay dividends, and their businesses have continued to do well this year despite the coronavirus pandemic.

Other stocks mentioned: MSFT
The Motley Fool - 3 weeks ago

A beaten-down biotech, a streaming star, and a coronavirus testing giant could be well-rounded additions to your portfolio.

Other stocks mentioned: DIS, VRTX
GuruFocus - 3 weeks ago

According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned health care stocks have outperformed the S&P 500 Index over the past 12 months through Dec. 22.

Other stocks mentioned: ABBV, LLY, NVO, TMO
The Motley Fool - 3 weeks ago

These are three winning stocks to put under your Christmas tree.

Other stocks mentioned: FVRR, PINS
Zacks Investment Research - 4 weeks ago

In the latest trading session, Abbott (ABT) closed at $108.09, marking a -0.81% move from the previous day.

Zacks Investment Research - 1 month ago

Abbott's (ABT) HeartMate 3 LVAD or heart pump is an implantable device that pumps blood through the body in people whose hearts are too weak to do so naturally.

PRNewsWire - 1 month ago

ABBOTT PARK, Ill., Dec. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company's HeartMate 3™ hea...

InvestorPlace - 1 month ago

If you have a stack of Benjamins lying around and collecting dust, put them to good use with these stocks to buy with $5,000. The post 9 Stocks to Buy With $5,000 in Starter Money appeared fir...

Other stocks mentioned: HMC, IMPUY, NEE, PG, POWW, QLYS, SHRMF, SQM
Seeking Alpha - 1 month ago

Abbott Laboratories is a great company that rewarded its shareholders with great returns. The company has recently rewarded shareholders with a massive 25% dividend raise.

CNBC - 1 month ago

"FDA continues to authorize COVID-19 tests that will give more Americans access to greater testing flexibility and options," FDA Commissioner Dr. Stephen Hahn said.

Forbes - 1 month ago

The sample does not need to be sent to a lab to be processed.

Market Watch - 1 month ago

Abbott Laboratories said Wednesday that its at-home BinaxNOW COVID-19 rapid COVID-19 test has been issued Emergency Use Authorization by the Food and Drug Administration. The company said Bina...

PRNewsWire - 1 month ago

ABBOTT PARK, Ill.,, Dec. 16, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for virtually...

Zacks Investment Research - 1 month ago

The test is set to be used on Abbott's (ABT) ARCHITECT and Alinity i platforms.

Forbes - 1 month ago

Abbott stock is up 23% since the start of the year and it has gained around 70% from its March lows. We believe that Abbott could offer an upside in the near term, as the company's revenues in...

Zacks Investment Research - 1 month ago

Abbott (ABT) closed at $106.79 in the latest trading session, marking a -0.23% move from the prior day.

Zacks Investment Research - 1 month ago

Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.

The Motley Fool - 1 month ago

And the goodies should keep on coming.

GuruFocus - 1 month ago

Dividend increase announcements continue to pile up as 2020 draws to a close. The health care sector remains one of my favorite places to find stocks offering solid yields and lengthy track re...

Other stocks mentioned: ABBV, BMY, PFE, VTRS
PRNewsWire - 1 month ago

ABBOTT PARK, Ill., Dec. 14, 2020 /PRNewswire/ -- Because supporting the immune system is top of mind for many people, Abbott (NYSE: ABT) is launching a new Pedialyte formulation specifically d...

The Motley Fool - 1 month ago

These coronavirus leaders are great picks for different reasons.

Other stocks mentioned: NVAX, PFE
The Motley Fool - 1 month ago

That's a big bump, even for the habitual payout raiser.

Market Watch - 1 month ago

Abbott said Friday its board has raised its quarterly dividend by 25% to 45 cents a share. The health care company has raised its dividend for 49 straight years, making it a member of the S&P ...

PRNewsWire - 1 month ago

ABBOTT PARK, Ill., Dec. 11, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 45 cents per share, ref...

The Motley Fool - 1 month ago

Solid dividends and solid businesses. Buffett likes these stocks -- and you might, too.

Other stocks mentioned: BAC, PFE
Zacks Investment Research - 1 month ago

Abbott (ABT) closed the most recent trading day at $106.32, moving -0.45% from the previous trading session.

Forbes - 1 month ago

Our indicative theme of Covid-19 Testing Stocks- which includes the stocks of companies that produce or carry out tests for the highly infectious virus - is up by about 51% year-to-date, on an...

Other stocks mentioned: QDEL, DGX, LH
GuruFocus - 1 month ago

Last month, the stock market responded positively to the news of a potential Covid-19 vaccine. While the initial impact of the news appears to be dissipating, now may be the right time to look...

Other stocks mentioned: CARR, TT, BSX, MDT
Investors Business Daily - 1 month ago

Medical company Abbott has now launched a handful of coronavirus tests, and the U.S. is paying $750 million for 150 million of one of its recently approved tests. So, is ABT stock a buy now?

InvestorPlace - 1 month ago

Under normal circumstances, an outgoing president would congratulate the incoming administration. But we're not living in normal circumstances, which bodes well for these stocks to buy during ...

Other stocks mentioned: COST, IP, NVAX, OLN, PG, POWW, VSTO, WPM
Zacks Investment Research - 1 month ago

Abbott's (ABT) next-generation FreeStyle Libre 2 system aims to provide a better quality of life to diabetics in Canada at the same affordable price of the current FreeStyle Libre system.

Zacks Investment Research - 1 month ago

In the latest trading session, Abbott (ABT) closed at $107.53, marking a -0.57% move from the previous day.

About ABT

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as... [Read more...]

Industry
Medical Devices
Founded
1888
CEO
Robert Ford
Employees
107,000
Stock Exchange
NYSE
Ticker Symbol
ABT
Full Company Profile

Financial Performance

In 2019, ABT's revenue was $31.90 billion, an increase of 4.34% compared to the previous year's $30.58 billion. Earnings were $3.69 billion, an increase of 55.70%.

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for ABT stock is "Buy." The 12-month stock price forecast is 121.76, which is an increase of 9.40% from the latest price.

Price Target
$121.76
(9.40% upside)
Analyst Consensus: Buy